Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 2/20 | 0.88 |
| ▸ | LCK | P06239 | 1/20 | 0.88 |
| ▸ | FYN | P06241 | 1/20 | 0.88 |
| ▸ | LMNA | P02545 | 3/20 | 0.56 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | THPO | P40225 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 3/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | MMP12 | P39900 | 1/20 | 0.39 |
| ▸ | CA4 | P22748 | 1/20 | 0.39 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL37010 | 1.00 | — | — | |
| Acetic Acid SCHEMBL28832781 | 1.00 | FFAR3 (0.88) | FFAR3LCKFYNLMNATSHR | |
| Acetic Acid SCHEMBL27648247 | 1.00 | — | — | |
| Acetic Acid SCHEMBL11435321 | 1.00 | FFAR3 (0.88) | FFAR3LCKFYNLMNATSHR | |
| Acetic Acid SCHEMBL5081257 | 1.00 | — | — | |
| Acetic Acid SCHEMBL23611021 | 0.94 | — | — | |
| Acetic Acid SCHEMBL11436800 | 0.94 | FFAR3 (0.78) | FFAR3LCKFYNLMNATSHR | |
| Acetic Acid SCHEMBL10792362 | 0.94 | FFAR3 (0.78) | FFAR3LCKFYNLMNATSHR | |
| Acetic Acid SCHEMBL17431238 | 0.94 | — | — | |
| Acetic Acid SCHEMBL5159895 | 0.94 | FFAR3 (0.78) | FFAR3LCKFYNLMNATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 208 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3713666-A1 | MICROCAPSULES AND PROCESSES FOR THEIR PREPARATION | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. (IL) | 2020-09-30 | — | — | EP | claimed |
| WO-2019102468-A1 | MICROCAPSULES AND PROCESSES FOR THEIR PREPARATION | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2019-05-31 | — | — | WO | claimed |
| US-9926402-B2 | Iminooxadiazinedione polyisocyanates | COVESTRO DEUTSCHLAND AG (DE) | 2018-03-27 | — | — | US | claimed |
| US-4158714-A | ANCHORING AGENTS | VITROFIL S.P.A. (IT) | 1979-06-19 | — | — | US | claimed |
| US-12616780-B2 | Medical devices containing compositions of poly(butylene succinate) and copolymers thereof | TEPHA, INC. (US) | 2026-05-05 | — | — | US | disclosed |
| US-12594361-B2 | Hernia repair, breast reconstruction and sling devices containing poly(butylene succinate) and copolymers thereof | TEPHA, INC. (US) | 2026-04-07 | — | — | US | disclosed |
| US-12570796-B2 | Polyester polymer nanocomposites | KINTRA FIBERS, INC. (US) | 2026-03-10 | — | — | US | disclosed |
| US-20260028448-A1 | BIODEGRADABLE RESIN COMPOSITION AND MOLDED BODY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2026-01-29 | — | — | US | disclosed |
| US-12478064-B2 | Microcapsules and processes for their preparation | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2025-11-25 | — | — | US | disclosed |
| US-20250333596-A1 | POLYESTER POLYMER NANOCOMPOSITES | KINTRA FIBERS INC (US) | 2025-10-30 | — | — | US | disclosed |
| US-12428523-B2 | Polyurethanes and moisture curable compositions including the same | H.B. FULLER COMPANY (US) | 2025-09-30 | — | — | US | disclosed |
| EP-4596603-A1 | METHOD FOR PRODUCING POLYESTER | Mitsubishi Chemical Corporation (JP) | 2025-08-06 | — | — | EP | disclosed |
| EP-0497349-B1 | Organosiloxane compositions exhibiting improved adhesion | DOW CORNING TORAY SILICONE (JP) | 1996-06-12 | — | — | EP | disclosed |
| EP-0497349-A2 | Organosiloxane compositions exhibiting improved adhesion | Dow Corning Toray Silicone Company, Limited (JP) | 1992-08-05 | — | — | EP | disclosed |
| EP-0493791-A1 | Curable organopolysiloxane composition exhibiting improved adhesion in the cured form | Dow Corning Toray Silicone Company, Limited (JP) | 1992-07-08 | — | — | EP | disclosed |
| US-4845134-A | ACRYLIC AMIDE POLYMER, PHENOLIC RESIN CROSSLINKER, PLUGGING PERMEABLE ZONES | PHILLIPS PETROLEUM COMPANY (US) | 1989-07-04 | — | — | US | disclosed |
| US-4799548-A | ENHANCED OIL RECOVERY, CROSSLINKING | PHILLIPS PETROLEUM COMPANY (US) | 1989-01-24 | — | — | US | disclosed |
| US-4483943-A | Gas conversion catalysts | UOP INC. (US) | 1984-11-20 | — | — | US | disclosed |
| US-4233253-A | Method for the preparation of metal salts of phosphorus acid esters | STANDARD OIL COMPANY (INDIANA) (US) | 1980-11-11 | — | — | US | disclosed |
| US-4158714-A | ANCHORING AGENTS | VITROFIL S.P.A. (IT) | 1979-06-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12594361-B2 | Hernia repair, breast reconstruction and sling devices containing poly(butylene succinate) and copolymers thereof | LRBA, MIF, LITAF | FFAR3 4575/4885LCK 3177/4885FYN 4599/4885 |
| US-12570796-B2 | Polyester polymer nanocomposites | SORD, BECN1, DSP | FFAR3 3455/4885LCK 3285/4885FYN 1583/4885 |
| US-20260028448-A1 | BIODEGRADABLE RESIN COMPOSITION AND MOLDED BODY | SLC39A7, UROD, RER1 | FFAR3 525/4885LCK 3798/4885FYN 2352/4885 |
| US-12616780-B2 | Medical devices containing compositions of poly(butylene succinate) and copolymers thereof | LRBA, LDHA, CD47 | FFAR3 2971/4885LCK 3005/4885FYN 2851/4885 |
| US-12478064-B2 | Microcapsules and processes for their preparation | LIPA, PHOSPHO1, CHMP4B | FFAR3 2964/4885LCK 1782/4885FYN 1552/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.